Effect of improved disease management strategies on hospital length of stay in the treatment of congestive heart failure

Clinical Therapeutics

Volumn 18, Issue 4, 1996, Pages 726-746

  Simons, W Robert ^a   Haim, Muriel ^a   Rizzo, John ^b   Zannad, Faiez ^c  

^a Pharmacoeconomics   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Centre d'Investigations Cliniques   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; BUMETANIDE; CAPTOPRIL; CARDIOVASCULAR AGENT; CHLOROTHIAZIDE; CHLORTALIDONE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL MALEATE; ETACRYNIC ACID; FOSINOPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROFLUMETHIAZIDE; INDAPAMIDE; LISINOPRIL; METHYCLOTHIAZIDE; METOLAZONE; QUINAPRIL; QUINETHAZONE; RAMIPRIL; SPIRONOLACTONE; TORASEMIDE; TRIAMTERENE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASODILATOR AGENT;

AGED; ARTICLE; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECONOMIC ASPECT; FEMALE; HEALTH STATUS; HOSPITAL; HOSPITALIZATION; HUMAN; INSURANCE; MALE; MANAGEMENT; MEDICAL RECORD; PROFIT; REIMBURSEMENT; UNITED STATES;

EID: 0029786112     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80223-2     Document Type: Article

References (39)

1. McKelvie R, McConachie D, Yusuf S. Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure. Eur Heart J. 1994;15(Suppl B):9-13.
2. Pitt B. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction. Cardiol Clin. 1994;12:101-114.
3. American Heart Association Facts, 1996.
4. Table 27. Discharges, total days of care, and program payments for Medicare beneficiaries discharged from short-stay hospitals, by principal diagnostic classification (MDC): Calendar year 1993. Health Care Financ Rev/Medicare and Medicaid Statistical Supplement. 1995;210.
5. Stearns SC. Hospital discharge decisions, health outcomes, and the use of unobserved information on case-mix severity. Health Serv Res. 1995;26:27-51.
6. Reiley P, Howard E. Predicting hospital length of stay in elderly patients with congestive heart failure. Nurs Econ. 1995; 13:210-216.
7. Anderson GF, Steinberg EP. Hospital read-missions in the Medicare population. NEJM. 1995;311:1349-1353.
8. Omenn GS, Conrad DA. Implications of DRGs for clinicians. NEJM. 1984;311: 1314-1317.
9. May JJ. Impact of diagnosis related groups on medical practice. Am J Cardiol. 1985; 56:16C-26C.
10. Knoebel SB. The effect of cost containment on the practice of cardiology: Predictions. Am J Cardiol. 1985;56:32C-34C.
11. Rock RC. Assuring quality of care under DRG-based prospective payment. Med Decis Mak. 1985;5:31-34.
12. Champlin L. DRGs: Putting the squeeze on your older patients? Geriatrics. 1985; 40:77-81.
13. Stern RS, Epstein AM. Institutional responses to prospective payment based on diagnosis-related groups. NEJM. 1985; 312:621-627.
14. Berenson RA, Pawlson LG. The Medicare prospective payment system and care of the frail elderly. J Am Geriatr Soc. 1984; 32:843-848.
15. Avorn A. Benefit and cost analysis in geriatric care. NEJM. 1984;310:1294-1301.
16. Iglehart JK. Health policy report: Early experience with prospective payment of hospitals. NEJM. 1986;314:1460-1464.
17. Williams SV. The impact of DRG-based prospective payment on clinical decision making. Med Decis Mak. 1985;5:23-29.
18. Epstein AM. Trends in length of stay and rates of readmission in Massachusetts: Implications for monitoring quality of care. Inquiry. 1991;28:19-28.
19. Willke RJ, Custer WS, Moser JW, Musacchio RA. Collaborative production and resource allocation: The consequences of prospective payment for hospital care. Q Rev Econ Bus. 1991;31:28-47.
20. Raffiee K, Wendel J. Interactions between hospital admissions, cost per day and average length of stay. Appl Econ. 1991; 23(Pt B):237-246.
21. Bergman U, Rich MW, Sperry JC, et al. Drug-related problems causing admissions to a medical clinic. Eur J Clin Pharmacol. 1981;20:193-200.
22. Levy M, Mermelstein L, Hemo D. Medical admissions due to noncompliance with drug therapy. Int J Clin Pharmacol Ther Toxicol. 1982;20:600-604.
23. Davidsen F, Haghfeld T, Gram LF, et al. Adverse drug reactions and drug non-compliance as primary causes of admissions to a cardiology department. Eur J Clin Pharmacol. 1988;34:83.
24. Kruse W, Weber E. Dynamics of drug regimen compliance - its assessment by microcomputer-based monitoring. Eur J Clin Pharmacol. 1990;38:561.
25. Fenn P, Davies P. Variations in length of stay: A conditional likelihood approach. J Health Econ. 1990;9:223-234.
26. Ellis RP, Ruhm CJ. Incentives to transfer patients under alternative reimbursement mechanisms. J Public Econ. 1988;37: 381-394.
27. Becker ER, Sloan FA. Utilization of hospital services: The roles of teaching, case mix, and reimbursement. Inquiry. 1983; 20:248-257.
28. Cammoodt LJ, Knickman JR. The effect of hospital characteristics and organizational factors on pre- and postoperative lengths of hospital stay. Health Serv Res. 1984;19:561-565.
29. Lave JR, Frank RG. Hospital supply response to prospective payment as measured by length of stay. Adv Health Econ Health Serv Res Series. 1990;1-26.
30. Projected CPDB (1993) Patient Characteristic Comparison with NHDS (1992). HCIA, Inc., March 1995.
31. Clare M, Sargent D, Moxley R, Forthman T. Reducing health and delivery costs using clinical paths: A case study on improving hospital profitability. J Health Care Finance. 1995;21:48-58.
32. Iglehart JK. Academic medical centers enter the market: The case of Philadelphia. NEJM, Health Policy Report. 1995;333: 1019-1023.
33. Large databases compare hospital profiles. OR Management, the Monthly Newsletter for OR Decision Makers. November 1995; 11(11).
34. Wen SW, Hernandez R, Naylor CD. Pitfalls in nonrandomized outcomes studies. JAMA. 1995;274:1687-1691.
35. Hlatky MA, Lee KL, Califf RM, et al. Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol. 1988;11:237-245.
36. Daley J, Hughes J, Fisher ES, Heeren T. Comorbidities, complications, and coding bias. JAMA. 1992;267:2197-2203.
37. Intriligator MD, Bodkin RG, Hsiao C, eds. Econometric Models, Techniques, and Applications. 2nd ed. New Jersey: Reed Reference Publishing; 1996.
38. Frank RG, Strobino DM, Salkever DS, Jackson CA. Updated estimates of the impact of prenatal care on birthweight outcomes by race. J Hum Resour. 1992; 27:629-642.
39. Weinberger M, Oddone EZ, Henderson WG. Does increased access to primary care reduce hospital readmissions? NEJM. 1996;334:1441-1447.